Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial. (Q54005841)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial. |
scientific article |
Statements
Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial. (English)
1 reference
1 reference
Donadio M
1 reference
Manzin E
1 reference
Berruti A
1 reference
Bottini A
1 reference
Gorzegno G
1 reference
Danese S
1 reference
DeFabiani E
1 reference
Sarobba MG
1 reference
Lorusso V
1 reference
Castiglione F
1 reference
Moro G
1 reference
Bumma C
1 reference
Dogliotti L
1 reference
1 May 2001
1 reference
47
1 reference
5
1 reference
391-396
1 reference
Identifiers
1 reference